相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nab-paclitaxel Monotherapy for Relapsed Small Cell Lung Cancer: Retrospective Analysis and Review
Makoto Nakao et al.
ANTICANCER RESEARCH (2020)
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
Francesco Gelsomino et al.
BRITISH JOURNAL OF CANCER (2020)
Solvent-based paclitaxel or nab-paclitaxel for heavily treated relapsed/refractory small cell lung cancer Retrospective single-institution observational study
Keiji Sugiyama et al.
MEDICINE (2019)
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer A retrospective analysis
Yujiro Naito et al.
MEDICINE (2017)
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial
Koichi Goto et al.
LANCET ONCOLOGY (2016)
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
Shinya Sakata et al.
LUNG CANCER (2016)
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer
Hironori Yoshida et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer
Juneko E. Grilley-Olson et al.
ONCOLOGIST (2015)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E. R. O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
分享论文
